Search Results 321-330 of 16665 for Androgens
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape. FEBS Open Bio. 2024 ...
- Current or prior androgen deprivation therapy. - Testosterone deficiency (total testosterone < 300 ng/dL). - Patients with Diabetes mellitus. Participating ...
Any medications known to affect physical function or muscle mass including androgen supplements, anti-androgens (such as luteinizing hormone-releasing hormone [ ...
Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in patients with breast cancer. Radiation therapy uses high-energy x-rays ...
Patients with a history of prostate cancer, requiring continued support with luteinizing hormone-releasing hormone (LHRH) agonists, with or without androgens, ...
... androgens or antiandrogens; Concurrent use of warfarin and strong inhibitors or CYP2D6 will not be allowed; A personal history or a strong family of ...
Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation ...
... androgen deprivation therapy; Must be willing to not add, delete or change their current bisphosphonate or denosumab usage throughout study treatment to ...
* Androgens. * Progestogens. * Current treatment for menopausal symptoms with cognitive behavioral therapy and/or hypnosis. * Current use of fezolinetant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.